Summary
This study focused on non-alcoholic fatty liver disease (NAFLD), which is associated with obesity, insulin resistance, and type 2 diabetes mellitus, and is becoming recognized as a component of the metabolic syndrome. NAFLD includes hepatic steatosis, inflammation and fibrosis and can ultimately lead to cirrhosis.
- cardiometabolic disorder
- obesity
- © 2006 MD Conference Express
Tools
Increased Adiposity and Hepatic Steatosis are Prevented in Mice Fed an Amylose-Rich Diet vs. a Diet High in Amylopectin
Permalink:
Table of contents
Cited By...
- No citing articles found.